The pharmacokinetics, pharmacodynamics, and clinical role of fixed dose combination of tenofovir disoproxil fumarate, lamivudine and reduced dose efavirenz (TLE-400) in treating HIV-1 infection.
Document Type
Journal Article
Publication Date
8-1-2018
Journal
Expert Opin Drug Metab Toxicol
Volume
14
Issue
8
Inclusive Pages
773-779
DOI
10.1080/17425255.2018.1498840
Keywords
Anti-HIV Agents; Benzoxazines; Dose-Response Relationship, Drug; Drug Combinations; HIV Infections; HIV-1; Humans; Lamivudine; Tenofovir
APA Citation
Dubrocq, G., & Rakhmanina, N. (2018). The pharmacokinetics, pharmacodynamics, and clinical role of fixed dose combination of tenofovir disoproxil fumarate, lamivudine and reduced dose efavirenz (TLE-400) in treating HIV-1 infection.. Expert Opin Drug Metab Toxicol, 14 (8). http://dx.doi.org/10.1080/17425255.2018.1498840
Peer Reviewed
1
